The global enteral feeding formulas market was valued at $6,298.6 million in 2022 and is projected to reach $ 12,706.8 million by 2032, registering a CAGR of 7.4% from 2023 to 2032.
Enteral feeding formulas, also known as tube feeding formulas, are specialized nutritional solutions designed for individuals who cannot consume food orally or have difficulty swallowing. These formulas are primarily used to provide essential nutrients, calories, vitamins, and minerals to patients who rely on tube feeding as their primary source of nutrition. Enteral feeding formulas come in various formulations to meet the specific nutritional needs of different patient populations, such as infants, adults, and elderly individuals. Key factors driving the growth of the enteral feeding formula market are the rise in the geriatric population and the surge in the prevalence of chronic diseases such as cancer, gastrointestinal disorders, and neurological conditions.
The escalating growth of the geriatric population has emerged as a significant driving force behind the expansion of the enteral feeding formula market. In recent years, the world has witnessed a remarkable increase in the number of elderly individuals, primarily attributed to advancements in medical care and a rise in life expectancy. According to United Nations World Population Prospects 2022, in 2022, there were 771 million people aged 65 years or over globally and the older population is projected to reach 994 million by 2030 and 1.6 billion by 2050. As people age, they often encounter various health challenges that can lead to difficulties in maintaining proper nutrition through regular dietary intake. Enteral feeding formulas are designed to provide essential nutrients directly to the digestive system, bypassing any potential obstacles that might hinder nutrient absorption or intake. Given that the elderly population is more susceptible to conditions that can impede their ability to consume a balanced diet, such as dysphagia, neurological disorders, or chronic illnesses, the demand for enteral feeding formulas has surged significantly. Elderly individuals frequently experience medical conditions that can diminish their appetite, impair their ability to swallow or reduce their capacity to absorb nutrients efficiently. As a result, healthcare professionals often turn to enteral feeding formulas to bridge these nutritional gaps and prevent malnutrition, which is a common concern among the elderly. Moreover, the convenience and precision of enteral feeding formulas make them an attractive option for both patients and caregivers. These formulas can be tailored to meet specific dietary requirements and health needs, ensuring that individuals receive the appropriate mix of vitamins, minerals, proteins, and calories. Thus, the rise in the geriatric population has emerged as a major catalyst for the expansion of the enteral feeding formula market.
Furthermore, the surge in the prevalence of chronic diseases such as cancer, gastrointestinal disorders, and neurological conditions has also emerged as a major driver for the enteral feeding formula market. Chronic diseases, such as diabetes, cancer, cardiovascular diseases, and neurological disorders, have become increasingly prevalent across various demographics, encompassing both developed and developing nations. This rise can be attributed to factors such as changing lifestyles, aging populations, and environmental influences. According to the American Cancer Society, in 2023, an estimated 12,380 new cases of laryngeal cancer were recorded. In addition, according to MedlinePlus, in 2022, it was estimated that more than half a million Americans are currently affected by this disorder. In many chronic diseases, patients often experience compromised nutritional status due to various reasons, including reduced appetite, difficulty swallowing, impaired digestion, and nutrient malabsorption. This necessitates the utilization of enteral feeding, which involves the delivery of nutrients directly into the gastrointestinal tract through a feeding tube. Enteral feeding formulas play a pivotal role in ensuring that patients receive the required nutrients, vitamins, and minerals in a controlled and easily digestible form. These formulas are specially designed to cater to the specific nutritional needs of patients with chronic diseases, addressing their medical condition while also supporting overall health and well-being. The integration of nutrition as a crucial component of chronic disease management further underscores the importance of enteral feeding formulas in improving patient outcomes and quality of life. Thus, the rise in the prevalence of chronic diseases is expected to drive the growth of the market. However, patient incompatibility and allergies might act as restraints for the enteral feeding formulas.
The enteral feeding formulas market is segmented on the basis of product type, age group, application, end user, and region. By product type, the market is categorized into standard formula, disease-specific formulas, peptide-based, and immune-modulating, blenderized. By age group, the market is categorized into adults and children. By application, the market is categorized into cancer, neurological disorders, gastrointestinal disorders, malnutrition, and others. By end user, the market is categorized into hospitals, long-term care facilities, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global enteral feeding formulas market are Abbott Laboratories, Nestlé, Danone S.A, Fresenius SE and Co. KGaA, B. Braun SE, Otsuka Holdings, Nutritional Medicinals, LLC, Kate Farms, Global Health Products Inc, DermaRite Industries, LLC.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
An in-depth analysis of the enteral feeding formulas market segmentation assists in determining the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes an analysis of the regional as well as global enteral feeding formulas market trends, key players, market segments, application areas, and market growth strategies.
Enteral feeding formulas, also known as tube feeding formulas, are specialized nutritional solutions designed for individuals who cannot consume food orally or have difficulty swallowing. These formulas are primarily used to provide essential nutrients, calories, vitamins, and minerals to patients who rely on tube feeding as their primary source of nutrition. Enteral feeding formulas come in various formulations to meet the specific nutritional needs of different patient populations, such as infants, adults, and elderly individuals. Key factors driving the growth of the enteral feeding formula market are the rise in the geriatric population and the surge in the prevalence of chronic diseases such as cancer, gastrointestinal disorders, and neurological conditions.
The escalating growth of the geriatric population has emerged as a significant driving force behind the expansion of the enteral feeding formula market. In recent years, the world has witnessed a remarkable increase in the number of elderly individuals, primarily attributed to advancements in medical care and a rise in life expectancy. According to United Nations World Population Prospects 2022, in 2022, there were 771 million people aged 65 years or over globally and the older population is projected to reach 994 million by 2030 and 1.6 billion by 2050. As people age, they often encounter various health challenges that can lead to difficulties in maintaining proper nutrition through regular dietary intake. Enteral feeding formulas are designed to provide essential nutrients directly to the digestive system, bypassing any potential obstacles that might hinder nutrient absorption or intake. Given that the elderly population is more susceptible to conditions that can impede their ability to consume a balanced diet, such as dysphagia, neurological disorders, or chronic illnesses, the demand for enteral feeding formulas has surged significantly. Elderly individuals frequently experience medical conditions that can diminish their appetite, impair their ability to swallow or reduce their capacity to absorb nutrients efficiently. As a result, healthcare professionals often turn to enteral feeding formulas to bridge these nutritional gaps and prevent malnutrition, which is a common concern among the elderly. Moreover, the convenience and precision of enteral feeding formulas make them an attractive option for both patients and caregivers. These formulas can be tailored to meet specific dietary requirements and health needs, ensuring that individuals receive the appropriate mix of vitamins, minerals, proteins, and calories. Thus, the rise in the geriatric population has emerged as a major catalyst for the expansion of the enteral feeding formula market.
Furthermore, the surge in the prevalence of chronic diseases such as cancer, gastrointestinal disorders, and neurological conditions has also emerged as a major driver for the enteral feeding formula market. Chronic diseases, such as diabetes, cancer, cardiovascular diseases, and neurological disorders, have become increasingly prevalent across various demographics, encompassing both developed and developing nations. This rise can be attributed to factors such as changing lifestyles, aging populations, and environmental influences. According to the American Cancer Society, in 2023, an estimated 12,380 new cases of laryngeal cancer were recorded. In addition, according to MedlinePlus, in 2022, it was estimated that more than half a million Americans are currently affected by this disorder. In many chronic diseases, patients often experience compromised nutritional status due to various reasons, including reduced appetite, difficulty swallowing, impaired digestion, and nutrient malabsorption. This necessitates the utilization of enteral feeding, which involves the delivery of nutrients directly into the gastrointestinal tract through a feeding tube. Enteral feeding formulas play a pivotal role in ensuring that patients receive the required nutrients, vitamins, and minerals in a controlled and easily digestible form. These formulas are specially designed to cater to the specific nutritional needs of patients with chronic diseases, addressing their medical condition while also supporting overall health and well-being. The integration of nutrition as a crucial component of chronic disease management further underscores the importance of enteral feeding formulas in improving patient outcomes and quality of life. Thus, the rise in the prevalence of chronic diseases is expected to drive the growth of the market. However, patient incompatibility and allergies might act as restraints for the enteral feeding formulas.
The enteral feeding formulas market is segmented on the basis of product type, age group, application, end user, and region. By product type, the market is categorized into standard formula, disease-specific formulas, peptide-based, and immune-modulating, blenderized. By age group, the market is categorized into adults and children. By application, the market is categorized into cancer, neurological disorders, gastrointestinal disorders, malnutrition, and others. By end user, the market is categorized into hospitals, long-term care facilities, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global enteral feeding formulas market are Abbott Laboratories, Nestlé, Danone S.A, Fresenius SE and Co. KGaA, B. Braun SE, Otsuka Holdings, Nutritional Medicinals, LLC, Kate Farms, Global Health Products Inc, DermaRite Industries, LLC.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the enteral feeding formulas market analysis from 2022 to 2032 to identify the prevailing enteral feeding formulas market opportunities.The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
An in-depth analysis of the enteral feeding formulas market segmentation assists in determining the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes an analysis of the regional as well as global enteral feeding formulas market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Average Selling Price Analysis / Price Point Analysis
- Criss-cross segment analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
- Market share analysis of players at global/region/country level
- SWOT Analysis
- Volume Market Size and Forecast
Key Market Segments
By Product Type
- Standard Formulas
- Disease-specific Formulas
- Peptide Based
- Immune modulating
- Blenderized
By Age Group
- Adult
- Child
By Application
- Cancer
- Neurological Disorders
- Gastrointestinal Disorders
- Malnutrition
- Others
By End user
- Hospital
- Long term Care Facilities
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Abbott Laboratories
- Nestle SA
- Fresenius SE & Co. KGaA
- Meiji Holdings Co. Ltd
- Medtrition Inc.
- B. Braun Melsungen AG
- Hormel Foods Corporation
- Nutritional Medicinals, LLC
- DermaRite Industries, LLC.
- Danone S.A
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT TYPE
CHAPTER 5: ENTERAL FEEDING FORMULAS MARKET, BY AGE GROUP
CHAPTER 6: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION
CHAPTER 7: ENTERAL FEEDING FORMULAS MARKET, BY END USER
CHAPTER 8: ENTERAL FEEDING FORMULAS MARKET, BY REGION
CHAPTER 9: COMPETITIVE LANDSCAPE
CHAPTER 10: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, the enteral feeding formulas market was valued at $6.3 billion in 2022, and is estimated to reach $12.7 billion by 2032, growing at a CAGR of 7.4% from 2023 to 2032. Enteral feeding formulas, also known as enteral nutrition or tube feeding formulas, are specially designed nutritional products that are used to provide essential nutrients to individuals who are unable to consume food orally or have difficulty in doing so. This can include patients with various medical conditions such as gastrointestinal disorders, cancer, neurological disorders, or those recovering from surgery. Enteral feeding formulas are typically administered through a tube, such as a nasogastric tube, gastrostomy tube, or jejunostomy tube.Key factors driving the growth of the enteral feeding formulas market include to surge in the geriatric population, and a rise in the global prevalence of chronic diseases such as gastrointestinal disorders, cancers, and neurological disorders.
The surge in the geriatric population has emerged as a significant driver for the enteral feeding formula market. This trend is a reflection of the global demographic shift towards an aging society, where a larger proportion of the population is reaching the elderly stage of life. For instance, according to the World Health Organization, in 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. As individuals age, they often experience a range of health issues that can make it challenging to maintain adequate nutrition through regular dietary means. Elderly people face difficulties in chewing, swallowing, or digesting food, which can lead to malnutrition and related health complications. Consequently, healthcare providers increasingly turn to enteral feeding formulas as a viable solution to ensure that elderly patients receive the necessary nutrients and calories they require for proper nourishment. The demand for enteral feeding formulas is further accentuated by the growing recognition of the importance of specialized nutrition for the elderly population. These formulations are tailored to address the unique dietary needs and medical conditions that often accompany aging, such as reduced muscle mass, compromised immune systems, and chronic illnesses like diabetes and gastrointestinal disorders. Moreover, the convenience and ease of administration of enteral feeding formulas make them an attractive option for both caregivers and healthcare facilities, as they can be administered through feeding tubes or oral supplements. Thus, the rise in geriatric population is expected to drive the growth of the market.Furthermore, the global prevalence of chronic diseases has been steadily rising, and this alarming trend has emerged as a major driver for the enteral feeding formula market.
Chronic diseases, such as diabetes, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), and cancer, have become increasingly common across the world due to factors like sedentary lifestyles, poor dietary choices, and an aging population. For instance, in 2023, the American Cancer Society estimated that around 1,958,310 new cancer cases in the U.S. These conditions often result in compromised nutritional status and difficulty in maintaining adequate oral food intake, leading to malnutrition. As a result, there is a growing need for specialized nutritional support, and enteral feeding formulas have gained prominence as a vital solution. Patients often experience difficulties in maintaining a balanced diet, leading to malnutrition and complications. Enteral feeding formulas are specially designed liquid nutrition supplements that are administered through tubes directly into the digestive tract. They are tailored to meet the specific dietary needs of individuals who are unable to consume regular food or absorb nutrients adequately through their digestive system.
The enteral feeding formulas market is segmented on the basis of product type, age group, application, end user, and region. By product type, the market is categorized into the standard formula, disease-specific formulas, peptide-based, and immune-modulating, blenderized. By age group, the market is categorized into adults and children. By application, the market is categorized into cancer, neurological disorders, gastrointestinal disorders, malnutrition, and others. By end user, the market is categorized into hospitals, long-term care facilities, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The key players profiled in the study include Abbott Laboratories, Nestlé, Danone S.A, Fresenius SE and Co. KGaA, B. Braun SE, Otsuka Holdings, Nutritional Medicinals, LLC, Kate Farms, Global Health Products Inc, and DermaRite Industries, LLC.
Key Market Insights
On the basis of product type, the standard formula segment was the highest contributor to the market in 2022. However, the disease-specific formulas segment is expected to register the fastest growth during the forecasted period.On the basis of age group, the adult was the highest contributor to the market in 2022.
On the basis of end users, the hospital segment was the highest contributor to the market in 2022.
On the basis of region, Europe generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Abbott Laboratories
- Nestle SA
- Fresenius SE & Co. KGaA
- Meiji Holdings Co. Ltd
- Medtrition Inc.
- B. Braun Melsungen AG
- Hormel Foods Corporation
- Nutritional Medicinals, LLC
- DermaRite Industries, LLC.
- Danone S.A
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
